A new study from UT Health San Antonio has provided insights into Alzheimer’s disease.

Scientists studying a Colombian family plagued by early-in-life Alzheimer's have found a rare gene variant that seems to delay initial symptoms by about five years.

Federal regulators are putting off a decision on Eli Lilly’s potential Alzheimer’s treatment with an unusual request to have an advisory committee examine the drug.

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

Eli Lilly and Co. says its experimental Alzheimer's drug appears to slow worsening of the mind-robbing disease.